David Lamond - 12 Dec 2023 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
Director
Signature
/s/ Brendan Hannah, Attorney-in-Fact for David Lamond
Issuer symbol
QNCX
Transactions as of
12 Dec 2023
Net transactions value
+$69,233
Form type
4
Filing time
14 Dec 2023, 18:21:33 UTC
Previous filing
07 Dec 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Purchase $300 +300 +0.01% $1.00 2,279,964 12 Dec 2023 By Blue Devil Trust dated 12/03/2010 F1
transaction QNCX Common Stock Purchase $22,774 +22,327 +0.98% $1.02 2,302,291 12 Dec 2023 Direct
transaction QNCX Common Stock Purchase $22,627 +22,627 +0.98% $1.00 2,324,918 13 Dec 2023 By Blue Devil Trust dated 12/03/2010 F1, F2
transaction QNCX Common Stock Purchase $23,532 +22,627 +0.97% $1.04 2,347,545 14 Dec 2023 By Blue Devil Trust dated 12/03/2010 F1, F3
holding QNCX Common Stock 301,829 12 Dec 2023 Direct
holding QNCX Common Stock 1,734,722 12 Dec 2023 By David A. Lamond Trust dated 2006 F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.99 to $1.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.98 to $1.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 Mr. Lamond is the trustee of David A. Lamond Trust dated 2006 (the "2006 Trust") and holds sole voting and dispositive power with respect to the shares held of record by the 2006 Trust.